Category: COVID-19

Commonwealth Fund Releases Report on Impact of U.S. COVID-19 Vaccination Efforts

The Commonwealth Fund this week issued a report exploring the impact of U.S. COVID-19 vaccination efforts, including an update on averted deaths, hospitalizations, and health care costs through March 2022. The Commonwealth Fund notes that COVID-19 cases, hospitalizations, and deaths have trended dramatically downward from their peaks earlier this year, but uncertainty still exists as…

Read More »

Biden-Harris Administration Issues Presidential Memorandum on Long COVID

The Biden-Harris Administration this week announced whole-of-government actions in response to millions of Americans’ experiences with prolonged illness from COVID-19, known as “Long COVID.” President Joseph R. Biden, Jr. issued a Presidential Memorandum directing the Secretary of Health and Human Services (HHS) to coordinate a new effort across the federal government to develop and issue…

Read More »

CDC Set to Terminate Title 42 Order on Migration Protocols

The U.S. Centers for Disease Control and Prevention (CDC) late last week announced it is issuing a Public Health Determination and terminating an order issued under Title 42, suspending the right to introduce migrants into the U.S. The termination is set to be implemented on May 23, 2022, enabling the Department of Homeland Security to…

Read More »

DHCS Launches Health Coverage Ambassador Campaign

This week, the California Department of Health Care Services (DHCS) announced it is launching a statewide effort to help Medi-Cal beneficiaries maintain their Medi-Cal coverage or be enrolled in other coverage. During the national public health emergency (PHE) in response to the COVID-19 pandemic, annual reevaluation of ongoing eligibility was temporarily halted to ensure vulnerable…

Read More »

FDA Authorizes Second COVID-19 Booster Dose for Older and Immunocompromised Individuals

On Tuesday, the U.S. Food and Drug Administration (FDA) authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 mRNA vaccines for older adults and certain immunocompromised individuals. The FDA previously authorized a single booster dose for certain immunocompromised individuals following completion of a three-dose primary vaccination series. According to the FDA,…

Read More »

Biden-Harris Administration Launches COVID.gov

This week, the Biden-Harris Administration this week launched www.COVID.gov, a new one-stop website for vaccines, tests, treatments, masks, and the latest COVID-19 guidance and information. As part of COVID.gov, a new Test-to-Treat locator is available to assist individuals access pharmacies and community health centers nationwide for COVID-19 testing and treatment. The Administration has launched over…

Read More »

Public Health Communications Collaborative to Hold Webinar on April 13

The Public Health Communications Collaborative, a partnership between the CDC Foundation, de Beaumont Foundation, and Trust for America’s Health (TFAH), will host a webinar on “Communicating Through COVID-19 and Beyond” on Wednesday, April 13 from 10:00 am to 11:00 am. The webinar will feature a discussion of insights for protecting the public health through the…

Read More »

FDA VRBPAC to Meet April 6 to Discuss Future COVID-19 Boosters

The U.S. Food and Drug Administration (FDA) announced it will convene a virtual meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Wednesday, April 6 to discuss considerations for future COVID-19 vaccine booster doses and the process for selecting specific strains of the SARS-CoV-2 virus for COVID-19 vaccines to address current and…

Read More »